CD4 and cancer: These results reveal the modulation of CD4+ T cells in AML, such as suppression of CD4+ T cell activities via downregulation of transcription factors and genes related to cancer control and defence and upregulation of genes in CD4+ T cells that promote leukaemogenesis and inflammatory signalling.